Editas Medicine (EDIT) Operating Expenses (2015 - 2025)

Editas Medicine (EDIT) has reported Operating Expenses for 11 consecutive years, with $32.1 million the latest figure, recorded in Q3 2025.

• In Q3 2025, Operating Expenses fell 51.18% year-over-year to $32.1 million; the TTM figure through Dec 2025 stood at $168.0 million (down 40.72% YoY), while the FY2024 annual figure was $283.5 million, up 14.62% from the prior year.
• Operating Expenses declined to $32.1 million in Q3 2025 per EDIT's latest filing, from $55.1 million in the prior quarter.
• Across five years, Operating Expenses topped out at $84.0 million in Q4 2023 and bottomed at $32.1 million in Q3 2025.
• Historically, Operating Expenses has averaged $61.2 million across 5 years, with a median of $60.6 million in 2022.
• Annual changes were most pronounced in 2024 — Operating Expenses jumped 54.14% — and 2025, when it sank 51.18%.
• Editas Medicine's Operating Expenses stood at $54.1 million in 2021, then rose by 29.41% to $70.0 million in 2022, then rose by 20.05% to $84.0 million in 2023, then decreased by 8.11% to $77.2 million in 2024, then plunged by 58.43% to $32.1 million in 2025.
• Business Quant data shows EDIT's Operating Expenses at $32.1 million in Q3 2025, $55.1 million in Q2 2025, and $80.8 million in Q1 2025.